Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. J of Skin [Internet]. 2024 Nov. 18 [cited 2026 Apr. 30];8(6):s506. Available from: https://skin.dermsquared.com/skin/article/view/3076